Zhangyan Lyu

The changes of subtype markers between first and second primary breast cancers

F. Song, Chenyang Li, Yubei Huang, 2023, Cancer medicine.

Development of a modified ABC method among Helicobacter pylori infected but serum pepsinogen test‐negative individuals

F. Song, Yuan Yuan, Kexin Chen, 2023, Helicobacter.

Risk-stratified multi-round PSA screening for prostate cancer integrating the screening reference level and subgroup-specific progression indicators

F. Song, Xing Wang, Fangfang Song, 2023, European Journal of Medical Research.

Comparisons of clinical characteristics, prognosis, epidemiological factors, and genetic susceptibility between HER2‐low and HER2‐zero breast cancer among Chinese females

F. Song, Huan Wang, Kexin Chen, 2023, Cancer medicine.

Associations of chest X-ray trajectories, smoking, and the risk of lung cancer in two population-based cohort studies

F. Song, Xing Wang, Chenyang Li, 2023, Frontiers in oncology.

A new risk stratification strategy for fatty liver disease by incorporating MAFLD and fibrosis score in a large US population

Wei Wang, Fangfang Song, H. Dai, 2022, Hepatology International.

Effects of joint screening for prostate, lung, colorectal, and ovarian cancer – results from a controlled trial

Fangfang Song, Yubei Huang, Ya Liu, 2024, Frontiers in oncology.

Preliminary effects of risk-adapted PSA screening for prostate cancer after integrating PRS-specific and age-specific variation

H. Dai, Yubei Huang, Ya Liu, 2024, Frontiers in genetics.